Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis
- PMID: 35908562
- DOI: 10.1016/S0140-6736(22)01384-8
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis
Comment on
-
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet. 2022 Jul 30;400(10349):369-379. doi: 10.1016/S0140-6736(22)01212-0. Lancet. 2022. PMID: 35908570 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
